Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conferences:

Conference Years:

Days Within Meeting:

Has CME:

Do I Have Access?

Access:

Availability:

Participation Type:

Categories:

Browse by: Sort by:
<< first | < prev page: of 9 records per page: next > | last >>
pages: 1 2 3 4 5 6 7 8 9 presentations: 1 to 25 of 211
Familial Lipid Disorders: What Every Lipid-Savvy Endocrinologist Needs to Know
Sergio Fazio, MD, PhD
Oregon Health and Science University, Portland, OR
Kenneth Feingold, MD
University of California, San Francisco, San Francisco, CA
from ENDO 2019 on March 23, 2019 2:00 PM-2:45 PM
Is HDL a Risk Factor or Risk Marker? The Clinical Take-Home Message
Jay Heinecke, MD
University of Washington Medical Center, Seattle, WA
from ENDO 2019 on March 24, 2019 9:15 AM-10:45 AM
New Cholesterol Guidelines 2018
Neil J Stone, MD
Northwestern University, Chicago, IL
from ENDO 2019 on March 24, 2019 9:15 AM-10:45 AM
Cholesterol-Carrying Lipoproteins and CVD Risk
Anne Carol Goldberg, MD
Washington Univ School of Med, Saint Louis, MO
from ENDO 2019 on March 24, 2019 9:15 AM-10:45 AM
Residual Risk: How to Assess Risk beyond the ASCVD Risk Calculator
Marc-Andre Cornier, MD
University of Colorado School of Medicine, Aurora, CO
from ENDO 2019 on March 24, 2019 1:45 PM-2:30 PM
Master Clinician: Management of Diabetes: Selecting Therapy Based on CVD Outcomes and Beyond
Carol H Wysham, MD
MultiCare Rockwood Clinic, Spokane, WA
Daniel J Drucker, MD
Mt Sinai Hospital, Toronto, ON
Jane E Reusch, MD
Rocky Mountain Regional VAMC, Aurora, CO
Hertzel C Gerstein, MD, MSc
McMaster University, Hamilton, ON
from ENDO 2019 on March 24, 2019 4:00 PM-5:00 PM
Pharmacotherapy for Lipid Disorders: Which Drugs for Which Disease
Robert Eckel, MD
University of Colorado Anschutz Medical Campus, Aurora, CO
from ENDO 2019 on March 25, 2019 2:00 PM-2:45 PM
Outstanding Educator Award Presented to Kenneth Burman, MD
Susan J Mandel, MD, MPH
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
from ENDO 2019 on March 25, 2019 3:00 PM-4:00 PM
Sidney H. Ingbar Award Presented to Carole Mendelson, PhD
Susan J Mandel, MD, MPH
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
from ENDO 2019 on March 25, 2019 3:00 PM-4:00 PM
Senescent cells: An Emerging Targetfor Diseases of Aging
Jan M van Deursen, PhD
Mayo Clinic, Rochester, MN
from ENDO 2019 on March 25, 2019 3:00 PM-4:00 PM
Targeting Cellular Senescence in Age-Related Osteoporosis and Frailty
Sundeep Khosla, MD
Mayo Clinic, Rochester, MN
from ENDO 2019 on March 25, 2019 3:00 PM-4:00 PM
Applying Multi-omics in Adrenal Hypertension
Maria-Christina Zennaro, MD, PhD
INSERM, Paris, France
from ENDO 2019 on March 25, 2019 4:15 PM-5:45 PM
The Expanding Spectrum of Primary Aldosteronism
Anand Vaidya, MD, MMSc
Brigham and Women's Hospital, Harvard Medical School, Boston, MA
from ENDO 2019 on March 25, 2019 4:15 PM-5:45 PM
Looking for Cellular Origins of Primary Aldosteronism
Hironobu Sasano, MD, PhD
Tohoku University School of Medicine, Sendai, Japan
from ENDO 2019 on March 25, 2019 4:15 PM-5:45 PM
Chylomicronemia: Is It Due to Genes or Environment or Both, and What Is the Contribution of Glycemic Control?
Alan Chait, MBChB, MD
University of Washington, Seattle, WA
from ENDO 2019 on March 26, 2019 8:00 AM-9:30 AM
Triglycerides and ASCVD in Patients with Diabetes and Insulin Resistance: Evidence Connecting Them and the Most Likely Mechanisms
Ira J Goldberg, MD
NYU Medical Center, New York, NY
from ENDO 2019 on March 26, 2019 8:00 AM-9:30 AM
Moderate Hypertriglyceridemia: Should It Be Treated, and If So, How?
P. Barton Duell, MD
Oregon Health and Science University, Portland, OR
from ENDO 2019 on March 26, 2019 8:00 AM-9:30 AM
Using New and Emerging Therapies in Managing of Hypercholesterolemia
Ira Goldberg, MD
NYU Medical Center, New York, New York
from Clinical Endocrinology Update 2018 on September 6, 2018 11:25 AM-11:55 AM
Risk Stratification: Coronary Calcium, ApoB, LDL Particle Size, Lp(a). Which Ones are Worthwhile and Why?
Ira Goldberg, MD
NYU Medical Center, New York, New York
from Clinical Endocrinology Update 2018 on September 6, 2018 1:25 PM-2:10 PM
Diabetes and Heart Failure
Matthew Cavender, MD, MPH
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
from Clinical Endocrinology Update 2018 on September 7, 2018 7:55 AM-8:25 AM
Q&A/Panel Discussion
Matthew Cavender, MD, MPH
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
Anders Carlson, MD
International Diabetes Center, Minneapolis, Minnesota
Mark Molitch, MD
Northwestern University, Chicago, Illinois
from Clinical Endocrinology Update 2018 on September 7, 2018 9:40 AM-9:55 AM
What To Do when Your Patient has a High (or a Low) HDL
Jeffrey Barton Boord, MD,MPH
Parkview Health, Fort Wayne, IN
from ENDO 2018 on March 17, 2018 2:00 PM-2:45 PM
Debate: The LDL Limbo. How Low Should You Go?
Alan Chait, MBBS, MD
Univ of WA, Seattle, WA
Steve Nissen, MD
Cleveland Clinic, Cleveland, OH
Henry N Ginsberg, MD
Columbia Univ College of Physicians and Surgeons, New York, NY
from ENDO 2018 on March 17, 2018 4:15 PM-5:15 PM
Chair
Ira J Goldberg, M.D.
NYU Med Ctr, New York, NY
from ENDO 2018 on March 18, 2018 8:00 AM-9:30 AM
Shared Mechanisms Linking Sugar-Regulated Carbohydrate and Lipid Metabolism
Mark A Herman, MD
Duke Univ Med Ctr, Durham, NC
from ENDO 2018 on March 18, 2018 8:00 AM-9:30 AM
<< first | < prev page: of 9 records per page: next > | last >>
pages: 1 2 3 4 5 6 7 8 9 presentations: 1 to 25 of 211